Novartis AG Other Comprehensive Income Net Of Tax Exchange Differences On Translation
Novartis AG (NVS) reported Other Comprehensive Income Net Of Tax Exchange Differences On Translation of $3.03 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation · last filed 2026-02-04
- Novartis AG other comprehensive income net of tax exchange differences on translation for the quarter ending 2025-06-30 was $2.11B, a 5185.00% increase year-over-year.
- Novartis AG other comprehensive income net of tax exchange differences on translation for the quarter ending 2024-06-30 was $40.00M, a 81.48% decline year-over-year.
- Novartis AG other comprehensive income net of tax exchange differences on translation for the quarter ending 2023-06-30 was $216.00M.
- Novartis AG other comprehensive income net of tax exchange differences on translation for the quarter ending 2022-06-30 was -$1.01B, a 267.33% decline year-over-year.
| Period end | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 3 month | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 6 month | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 12 month |
|---|---|---|---|
| 2025-12-31 | $3.03B 20-F · filed 2026-02-04 | ||
| 2025-06-30 | $2.11B 6-K · filed 2025-07-17 | $2.83B 6-K · filed 2025-07-17 | |
| 2024-12-31 | -$1.57B 20-F · filed 2026-02-04 | ||
| 2024-06-30 | $40.00M 6-K · filed 2025-07-17 | -$1.36B 6-K · filed 2025-07-17 | |
| 2023-12-31 | $1.38B 20-F · filed 2026-02-04 | ||
| 2023-06-30 | $216.00M 6-K · filed 2024-07-18 | $522.00M 6-K · filed 2024-07-18 | |
| 2022-12-31 | -$450.00M 20-F · filed 2025-01-31 | ||
| 2022-06-30 | -$1.01B 6-K · filed 2023-07-18 | -$1.28B 6-K · filed 2023-07-18 | |
| 2021-12-31 | -$4.76B 20-F · filed 2024-01-31 | ||
| 2021-06-30 | $606.00M 6-K · filed 2022-07-19 | -$1.55B 6-K · filed 2022-07-19 | |
| 2020-12-31 | $3.19B 20-F/A · filed 2023-05-15 | ||
| 2020-06-30 | $380.00M 6-K · filed 2021-07-21 | $382.00M 6-K · filed 2021-07-21 | |
| 2019-12-31 | $352.00M 20-F · filed 2022-02-02 | ||
| 2019-06-30 | $525.00M 6-K · filed 2020-07-21 | $189.00M 6-K · filed 2020-07-21 | |
| 2018-12-31 | $315.00M 20-F · filed 2021-01-26 | ||
| 2018-06-30 | -$809.00M 6-K · filed 2019-07-18 | $233.00M 6-K · filed 2019-07-18 | |
| 2017-12-31 | $2.21B 20-F · filed 2020-01-29 | ||
| 2017-06-30 | $1.59B 6-K · filed 2018-07-18 | $2.25B 6-K · filed 2018-07-18 | |
| 2016-12-31 | -$2.39B 20-F · filed 2019-01-30 | ||
| 2015-12-31 | -$1.66B 6-K · filed 2018-01-24 |